MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2018 International Congress

    Artisanal formulations of Cannabis in Movement Disorders. The real-life perspective in a population from Buenos Aires, Argentina. Preliminary report

    M. Cesarini, JL. Etcheverry, N. Gonzalez Rojas, G. Da Prat, V. Parisi, G. Rojas, G. Persi, E. Gatto (Buenos Aires, Argentina)

    Objective: To describe the effect of artisanal formulations of CBDo in a retrospective case series of patients with a variable spectrum of movement disorders, who…
  • 2018 International Congress

    The effects of bright light therapy on depression, sleep and circadian rhythm in patients with Parkinson’s disease and a depressive disorder: Results of a double-blind randomized controlled trial

    S. Rutten, C. Vriend, J. Smit, H. Berendse, E. van Someren, A. Hoogendoorn, J. Twisk, Y. vd Werf, O. vd Heuvel (Amsterdam, Netherlands)

    Objective: The aim of this study was to assess the efficacy of Bright Light Therapy (BLT) in reducing depressive symptoms in patients with Parkinson’s disease…
  • 2018 International Congress

    Effects of non-invasive brain stimulation on motor-speech disorders in Parkinson’s disease

    I. Rektorova, P. Klobusiakova, L. Brabenec, J. Mekyska, Z. Galaz, M. Kostalova (Brno, Czech Republic)

    Objective: To investigate acute effects of repetitive transcranial magnetic stimulation (rTMS) of the motor and auditory feedback area on hypokinetic dysarthria in Parkinson’s disease (PD)…
  • 2018 International Congress

    Objective analysis of walking tremor in Parkinson’s disease: A spectrum of classical rest tremor?

    N. Dadphan, O. Jitkritsadakul, C. Anan, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To delineate objective characteristics of walking tremor in PD patients in relation to classical parkinsonian rest tremor with inertial sensors. Background: Tremors in PD…
  • 2018 International Congress

    Neurorestorative effects of glycine transporter 1-inhibitor and D-Serine in a mouse model of nigrostriatal dopaminergic degeneration

    V. Francardo, Y. Schmitz, D. Sulzer, M.A. Cenci (Lund, Sweden)

    Objective: We set out to evaluate potential neurorestorative effects of the GlyT1 inhibitor ACPPB vis-à-vis D-Serine in the intrastriatal 6-OHDA mouse model of Parkinson’s disease.…
  • 2018 International Congress

    Sex differences by design and outcome in the Safety of Urate Elevation in PD (SURE-PD) trial

    M. Schwarzschild, E. Macklin, R. Bakshi, S. Bhattacharyya,, R. Logan, A. Ascherio; on behalf of the Parkinson Study Group SURE-PD Investigators (Boston, MA, USA)

    Objective: To investigate whether women and men with Parkinson's disease (PD) may differ in their biochemical and clinical responses to long-term treatment with urate-elevating inosine.…
  • 2018 International Congress

    Five Year Outcomes of a Prospective, Multicenter Trial Evaluating Deep Brain Stimulation with a New Multiple Source, Constant Current Rechargeable System in Parkinson’s Disease

    L. Timmermann, R. Jain, N. Van Dyck, L. Chen, T. Brücke, F. Siejo, E. Suarez-San Martin, V. Visser-Vandewalle, M. Barbe, S. Gill, A. Whone, M. Porta, D. Servello, F. Alesch (Köln, Germany)

    Objective: To evaluate the long term follow up of patients in the VANTAGE Study that employed a Deep Brain Stimulation (DBS) system with multiple independent…
  • 2018 International Congress

    Emotional Lability Following Deep Brain Stimulation Targeting Subthalamic Nucleus, Globus Pallidus Internus and Ventrointermedial Nucleus of Thalamus

    S. Joza, T. Sankar, F. Ba (Edmonton, AB, Canada)

    Objective: This is the first report of acute, stimulation‐locked, reversible psychiatric symptoms induced by GPi‐DBS in dystonia. We here demonstrate three cases where patients had…
  • 2018 International Congress

    Deep brain stimulation for monogenic Parkinson’s disease: A systematic review

    T. Kuusimäki, J. Korpela, E. Pekkonen, M. Martikainen, A. Antonini, V. Kaasinen (Turku, Finland)

    Objective: The aim was to systematically investigate the outcome of deep brain stimulation (DBS) in genetic Parkinson’s disease (PD) compared to the patients with documented…
  • 2018 International Congress

    Mingo Supplement Trial: An Open-Labeled Randomized-Controlled Trial in X-linked Dystonia-Parkinsonism patients in the Province of Capiz, Philippines

    P. Acuna, G. Solinap, M. Ang, J. de Guzman, C. Go (Charlestown, MA, USA)

    Objective: To see whether increasing the caloric intake of patients by 480 calories per day using a locally sourced food supplement, Mingo, would raise the…
  • « Previous Page
  • 1
  • …
  • 214
  • 215
  • 216
  • 217
  • 218
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley